Welcome to our new website! If this is the first time you are logging in on the new site, you will need to reset your password. Please contact us at raps@raps.org if you need assistance.
The regulatory function is vital in making safe and effective healthcare products available worldwide. Individuals who ensure regulatory compliance and prepare submissions, as well as those whose main job function is clinical affairs or quality assurance are all considered regulatory professionals.
Resources, news and special offers to support you and your professional development during this difficult time.
One of our most valuable contributions to the profession is the Regulatory Code of Ethics. The Code of Ethics provides regulatory professionals with core values that hold them to the highest standards of professional conduct.
Your membership opens the door to free learning resources on demand. Check out the Member Knowledge Center for free webcasts, publications and online courses.
Like all professions, regulatory is based on a shared set of competencies. The Regulatory Competency Framework describes the essential elements of what is required of regulatory professionals at four major career and professional levels.
Download your copy of the new events calendar and see all the online workshops, conferences, RAC exams and European online workshops RAPS has planned for 2021 at a glance.
An invaluable resource for any professional engaged in designing, composing, compiling, or commenting on regulatory documentation
From self-assessments to help you identify your strengths and areas to focus on to reference books and online courses that will help you fill in the gaps in your regulatory knowledge, RAPS has the resources to help you prepare for the RAC exam.
The site navigation utilizes arrow, enter, escape, and space bar key commands. Left and right arrows move across top level links and expand / close menus in sub levels. Up and Down arrows will open main level menus and toggle through sub tier links. Enter and space open menus and escape closes them as well. Tab will move on to the next part of the site rather than go through menu items.
Posted 10 April 2017 | By Michael Mezher
The European Medicines Agency (EMA) has proposed to change the agency's guideline for investigating drug interactions.
The guideline, last updated in 2012, details how drugmakers should conduct interaction studies to evaluate the potential for drug-drug and drug-food interactions.
"Drug-drug interactions are a common problem during drug treatment and give rise to a large number of hospital admissions as a result of medically important, sometimes serious or even fatal adverse events," EMA writes in its current guideline.
The agency also says that studying drug interactions is growing more important as the European population ages, with more patients taking multiple drugs simultaneously.
According to the concept paper, the guideline needs to be updated to add additional study design recommendations and considerations, as well as clarifications on a handful of issues covered by the previous revision related to in vitro and in vivo studies and labelling.
As such, EMA is asking stakeholders, including drugmakers, academia, healthcare professionals and other regulators, to provide input on the concept paper during a three-month public consultation.
Following the public consultation, EMA says it will begin working on draft revisions, taking into account the comments received.
EMA
Tags: drug-drug interaction, drug-food interaction
Regulatory Focus newsletters
All the biggest regulatory news and happenings.